Cronos Group Inc vs Financial Select Sector SPDR Fund — how do they compare? Cronos Group Inc trades at $3.23 (market cap $1.20B), while Financial Select Sector SPDR Fund trades at $54.3 (market cap $50.96B). The key difference: Financial Select Sector SPDR Fund is far larger — about 42.5× Cronos Group Inc's market cap, and Cronos Group Inc is trading nearer its 52-week high, Financial Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and Financial Select Sector SPDR Fund for 104 Days on average.
| CRON | XLF | |
|---|---|---|
Market Cap | $1.20B | $50.96B |
Volume | 450,387 | 35,821,731 |
Sector | Health | — |
52-Week High | $3.55 | $58.55 |
52-Week Low | $2.30 | $47.80 |
Typical Hold Time | 22 Days | 104 Days |
Enterprise Value | $401.73M | — |
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.24, down 1.37% on the day, with a bearish technical signal and neutral oscillators. The company reported a net loss of $9.45M in 2025 despite revenue growth to $146.59M, but recent quarters show earnings beats. Analyst sentiment is mixed with 20% buy, 60% hold, and 20% sell ratings. Recent news highlights investor day events and international expansion efforts.
The outlook is cautious; profitability improvements and cash flow generation are key catalysts, but high valuation multiples and negative net cash flow pose risks. Regulatory developments in cannabis markets and execution on growth targets will be critical for stock performance.
XLF trades at $53.75, down 0.48% with a bearish technical signal as financial stocks lag the broader market. The ETF faces headwinds from rising interest rates and regulatory changes, though higher rates could benefit bank profitability. Recent news highlights sector rotation into financials by fund managers despite underperformance relative to the S&P 500.
The outlook remains cautious with technical indicators showing bearish momentum, though oversold conditions may present entry opportunities. Key risks include interest rate sensitivity and regulatory uncertainty, while potential catalysts include continued Fed tightening and improved bank earnings. Wall Street sentiment is mixed with institutional positioning favoring financials.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →The fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: diversified financial services; insurance; banks; capital markets; mortgage real estate investment trusts; consumer finance; thrifts; and mortgage finance. The fund is non-diversified.
Read more on XLF →